Domainex Ltd-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Domainex Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8014044
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月22日
◆ページ数:20
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Domainex Ltd (Domainex) is a biotechnology company that provides drug discovery technologies and services. The company offers drug discovery services in the areas of medicinal chemistry, computational chemistry, protein expression and purification, biochemical assay development, DMPK analysis, cell biology, combinatorial domain hunting, and hit identification using virtual or fragment-based approaches. It provides methyltransferases and solutions for the treatment of novel treatment for inflammatory diseases such as DMXD-011, a small-molecule orally-bio available inhibitor for rheumatoid arthritis and lupus. Domainex develops a range of drug target classes which include kinases, proteases, ion channels, proteins involved in epigenetics and protein-protein interactions. The company provides discovery technology platform such as combinatorial domain hunting and fragment-based screening. It develops therapies for oncology and autoimmune diseases. Domainex is headquartered in Saffron Walden, the UK.

Domainex Ltd – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Domainex Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Domainex Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Domainex Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Domainex Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Domainex Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Domainex Ltd, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Domainex Raises Funds In First Tranche Of US$2.3 Million Venture Financing Round 10
Partnerships 11
Domainex Expands its Agreement with Imperial College London 11
ZoBio and Domainex Enter into Agreement with Forma Therapeutics 12
Domainex Extends Co-Development Agreement with Auspherix 13
Horizon Discovery Enters Into Agreement With Domainex To Support Oncology Program 14
Domainex Ltd – Key Competitors 15
Domainex Ltd – Key Employees 16
Domainex Ltd – Locations And Subsidiaries 17
Head Office 17
Recent Developments 18
Corporate Communications 18
Mar 30, 2017: Domainex appoints Timo Veromaa as Executive Chairman 18
Product News 19
04/26/2016: Queen’s University Belfast and Domainex Win Late-Stage Award to Progress Novel Lung Cancer Drug Candidate into the Clinic 19
Appendix 20
Methodology 20
About GlobalData 20
Contact Us 20
Disclaimer 20

List of Tables
Domainex Ltd, Pharmaceuticals & Healthcare, Key Facts 2
Domainex Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Domainex Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Domainex Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Domainex Ltd, Deals By Therapy Area, 2011 to YTD 2017 8
Domainex Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Domainex Raises Funds In First Tranche Of US$2.3 Million Venture Financing Round 10
Domainex Expands its Agreement with Imperial College London 11
ZoBio and Domainex Enter into Agreement with Forma Therapeutics 12
Domainex Extends Co-Development Agreement with Auspherix 13
Horizon Discovery Enters Into Agreement With Domainex To Support Oncology Program 14
Domainex Ltd, Key Competitors 15
Domainex Ltd, Key Employees 16

★海外企業調査レポート[Domainex Ltd-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • C&A:戦略・SWOT・企業財務分析
    C&A - Strategy, SWOT and Corporate Finance Report Summary C&A - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing …
  • SS&C Advent:企業の戦略的SWOT分析
    SS&C Advent - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • 8point3 Energy Partners LP (CAFD):電力:M&Aディール及び事業提携情報
    Summary 8point3 Energy Partners LP (8point3 Energy) is a renewable energy company that owns, operates and acquires solar energy generation projects. The company offers operation and maintenance, project development, and technical services. It operates residential, commercial, industrial, and utility …
  • Iberia Lineas Aereas De Espana, Sa
    Iberia Lineas Aereas De Espana, Sa - Strategy, SWOT and Corporate Finance Report Summary Iberia Lineas Aereas De Espana, Sa - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • AECOM (ACM):石油・ガス:M&Aディール及び事業提携情報
    Summary AECOM, formerly AECOM Technology Corporation, is a provider of engineering, consulting and project management services. The company primarily designs, builds, operates and finances various infrastructure assets for businesses, governments, and organizations. Its service offerings include ass …
  • NSK Ltd.:企業の戦略・SWOT・財務情報
    NSK Ltd. - Strategy, SWOT and Corporate Finance Report Summary NSK Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …
  • Key Energy Services, Inc.:企業の戦略・SWOT・財務分析
    Key Energy Services, Inc. - Strategy, SWOT and Corporate Finance Report Summary Key Energy Services, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Codexis Inc (CDXS)-製薬・医療分野:企業M&A・提携分析
    Summary Codexis Inc (Codexis) is a biotechnology company, which focuses on the development of biocatalysts for commercial scale production of fine chemicals and pharmaceuticals. The company’s product portfolio includes pharmaceutical enzymes and intermediates, active pharmaceutical ingredients (APIs …
  • Dana Inc:企業の戦略・SWOT・財務分析
    Dana Inc - Strategy, SWOT and Corporate Finance Report Summary Dana Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …
  • Komunalna poistovna, a.s. Vienna Insurance Group:企業の戦略的SWOT分析
    Komunalna poistovna, a.s. Vienna Insurance Group - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competit …
  • Daito Trust Construction Co., Ltd.:企業の戦略・SWOT・財務分析
    Daito Trust Construction Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Daito Trust Construction Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • Innergex Renewable Energy Inc (INE)-エネルギー分野:企業M&A・提携分析
    Summary Innergex Renewable Energy Inc. (Innergex) is an electricity services company that develops, owns, and operates renewable power-generating facilities. It sells electricity that is generated from hydro, wind, and solar sources. The company sells electricity through long-term power purchase agr …
  • Supreme Pharmaceuticals Inc (SL)-製薬・医療分野:企業M&A・提携分析
    Summary Supreme Pharmaceuticals Inc (Supreme Pharmaceuticals), formerly Supreme Resources Ltd is a medial products production and distributing company. The company's products include medical marijuana, sun grown marijuana and others. It offers services such as production, exploration, trading, culti …
  • Morphotek Inc-製薬・医療分野:企業M&A・提携分析
    Summary Morphotek Inc (Morphotek), a subsidiary of Eisai Co Ltd is a clinical-stage biotech company that develops novel classes of biological based products. The company offers a pipeline of monoclonal antibodies, antibody drug conjugates, and bispecific antibodies for the treatment of cancer, infla …
  • Yihai International Holding Ltd (1579):企業の財務・戦略的SWOT分析
    Yihai International Holding Ltd (1579) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths a …
  • Progenitor Cell Therapy LLC-製薬・医療分野:企業M&A・提携分析
    Summary Progenitor Cell Therapy LLC (PCT), a subsidiary of Caladrius Biosciences Inc is an external development and manufacturing company that offers cell therapy products. The company offers services that include cell and tissue processing; storage, distribution and delivery; consulting and regulat …
  • AusNet Services Ltd (AST):電力:M&Aディール及び事業提携情報
    Summary AusNet Services Ltd. (AusNet) is a diversified energy network business entity that transmits and distributes power and distributes gas. It owns and manages electricity transmission network in Victoria; and delivers electricity to various customer connection points in eastern Victoria includi …
  • RCR Tomlinson Ltd (RCR):企業の財務・戦略的SWOT分析
    RCR Tomlinson Ltd (RCR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Amarin Corp Plc (AMRN)-製薬・医療分野:企業M&A・提携分析
    Summary Amarin Corp Plc (Amarin) is a biopharmaceutical company which develops and commercializes medicines for cardiovascular domain. The company's lead product Vascepa (icosapent ethyl) is a US FDA approved single-molecule prescription capsule used as an adjunct to diet, for the reduction of trigl …
  • AB Volvo:企業の戦略・SWOT・財務情報
    AB Volvo - Strategy, SWOT and Corporate Finance Report Summary AB Volvo - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆